Specifically targeting the up-regulated kinases such as the epidermal growth factor receptor tyrosine kinase (EGFR TK) and interrupting the signaling intermediates such as mitogen-activated protein kinase (MAPK) and Janus kinase (JAK)/STAT have been a promising strategy to reverse the rate of cancer-related mortality. Here, EGFR is linked to cancer.